Decoding the CAF–TAM axis: multi-omics dissection and therapeutic targeting of stromal–immune crosstalk in the tumor microenvironment
Authors:
Top Cited Papers
Open Access
- 18 April 2026
- journal article
- review article
- Published by Springer Nature in Cell Death & Disease
- Vol. 17 (1)
Abstract
Cancer-associated fibroblasts (CAFs) and tumor-associated macrophages (TAMs) are pivotal stromal and immune components of the tumor microenvironment (TME) that orchestrate immune evasion, metabolic reprogramming, and therapeutic resistance. Regions enriched in CAFs are frequently accompanied by dense TAM infiltration, underscoring their close structural and functional interdependence. Recent advances in single-cell, multi-omics, and spatial profiling technologies have revolutionized our understanding of the spatiotemporal heterogeneity, lineage evolution, and bidirectional signaling between CAFs and TAMs. In this review, we summarize the latest progress from transcriptomic, epigenomic, metabolomic, and spatial multi-omics studies, highlighting the diverse CAF/TAM subpopulations, their intercellular communication networks, and their collective roles in extracellular matrix remodeling, immune suppression, metabolic adaptation, and angiogenesis. Finally, we discuss emerging therapeutic strategies targeting CAFs, TAMs, and their interactive pathways, offering new conceptual and translational insights into reprogramming the immunosuppressive TME and enhancing antitumor efficacy.Keywords
This publication has 289 references indexed in Scilit:
- In vitro models of cancer‐associated fibroblast heterogeneity uncover subtype‐specific effects of CRISPR perturbationsMolecular Oncology, 2025
- Nicotinamide N‐methyltransferase negatively regulates metastasis‐promoting property of cancer‐associated fibroblasts in lung adenocarcinomaCancer Communications, 2024
- Single‐cell sequencing combined with spatial transcriptomics reveals that the IRF7 gene in M1 macrophages inhibits the occurrence of pancreatic cancer by regulating lipid metabolism‐related mechanismsClinical and Translational Medicine, 2024
- Tumor microenvironment signaling and therapeutics in cancer progressionCancer Communications, 2023
- Single‐Cell Transcriptomic Analysis of Primary and Metastatic Tumor Ecosystems in Esophageal Squamous Cell CarcinomaAdvanced Science, 2023
- CD47‐SIRPα blocking‐based immunotherapy: Current and prospective therapeutic strategiesClinical and Translational Medicine, 2022
- Functions and clinical significance of mechanical tumor microenvironment: cancer cell sensing, mechanobiology and metastasisCancer Communications, 2022
- Smad3 Promotes Cancer‐Associated Fibroblasts Generation via Macrophage–Myofibroblast TransitionAdvanced Science, 2021
- CD63+ Cancer‐Associated Fibroblasts Confer Tamoxifen Resistance to Breast Cancer Cells through Exosomal miR‐22Advanced Science, 2020
- Effect of Adding Motolimod to Standard Combination Chemotherapy and Cetuximab Treatment of Patients With Squamous Cell Carcinoma of the Head and NeckJAMA Oncology, 2018